Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.25
+0.07 (0.63%)
Apr 30, 2026, 3:00 PM CST

SHA:603439 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,5534,7355,2057,7385,6376,483
Market Cap Growth
-13.65%-9.02%-32.74%37.27%-13.05%-21.44%
Enterprise Value
4,9525,2855,4457,4215,3426,161
Last Close Price
11.2511.7012.6318.0813.0615.03
PE Ratio
96.19102.3818.9926.4428.0142.58
Forward PE
-10.6013.8126.53--
PS Ratio
2.722.782.434.734.696.91
PB Ratio
2.923.133.264.534.556.28
P/TBV Ratio
5.235.786.8811.375.816.41
P/FCF Ratio
27.2134.1384.1246.0732.5150.27
P/OCF Ratio
23.5628.7748.6127.9719.2241.82
EV/Sales Ratio
2.953.102.544.544.456.56
EV/EBITDA Ratio
17.5419.4713.5424.4424.2437.78
EV/EBIT Ratio
23.8726.6016.5827.7726.1140.56
EV/FCF Ratio
29.5938.0988.0044.1830.8147.77
Debt / Equity Ratio
0.450.500.380.330.170.19
Debt / EBITDA Ratio
2.512.771.501.830.931.23
Debt / FCF Ratio
4.235.479.813.301.191.55
Net Debt / Equity Ratio
0.210.230.07-0.04-0.34-0.43
Net Debt / EBITDA Ratio
1.181.290.27-0.22-1.93-2.71
Net Debt / FCF Ratio
1.982.521.74-0.40-2.45-3.43
Asset Turnover
0.560.560.700.690.750.71
Inventory Turnover
1.731.882.633.203.644.07
Quick Ratio
1.321.231.161.561.942.79
Current Ratio
1.571.481.461.782.143.05
Return on Equity (ROE)
3.17%3.10%16.94%20.01%16.91%14.76%
Return on Assets (ROA)
4.36%4.11%6.71%7.05%7.94%7.13%
Return on Invested Capital (ROIC)
7.87%7.92%16.91%19.22%25.16%21.45%
Return on Capital Employed (ROCE)
11.20%11.00%16.80%12.80%16.10%14.50%
Earnings Yield
1.07%0.98%5.27%3.78%3.57%2.35%
FCF Yield
3.68%2.93%1.19%2.17%3.08%1.99%
Dividend Yield
3.04%-2.69%1.11%0.77%-
Payout Ratio
329.73%349.04%37.97%17.40%4.43%72.37%
Buyback Yield / Dilution
-0.67%-2.81%0.79%-0.36%0.19%-5.14%
Total Shareholder Return
2.37%-2.81%3.48%0.75%0.96%-5.14%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.